Medication info
Telmisartan and Amlodipine 40/5 mg Tablet

Telmisartan and Amlodipine 40/5 mg Tablet

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Green Cross Corporation
Appearance
Biconvex, double-layered tablet, white and light blue in color
Packaging
30 tablets (10 tablets/PTP X 3), 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201606829 · Approved 2016.11.30 · Insurance code 698003350

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients 75 years of age or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Child dose
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Green Cross Corporation

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively control the blood pressure of patients with essential hypertension whose blood pressure is not sufficiently controlled with monotherapy of Telmisartan or Amlodipine.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients 75 years of age or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.

Child dose

○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. If pregnancy is confirmed, this medication should be discontinued as soon as possible. This medication should not be administered to individuals with known allergies to the active ingredients or similar substances, pregnant or potentially pregnant women, breastfeeding individuals, those with obstructive biliary disorders, severe liver impairment, specific heart diseases, severe hypotension, cardiogenic shock, unstable heart failure post-acute myocardial infarction, specific intolerances to other medications, or those with diabetes or severe renal impairment. Caution should be exercised when administering to patients with primary aldosteronism, certain heart valve diseases, liver impairment, gastrointestinal diseases, renal artery hypertension, patients requiring dialysis for renal failure, the elderly, and those using other specific antihypertensive medications. Common side effects such as dizziness and peripheral edema may occur, and rare but serious adverse reactions such as syncope may happen. This medication should not be taken during pregnancy; those planning a pregnancy should switch to another safe antihypertensive. Due to the risk of hypotension, patients with low fluid or electrolyte levels should correct their conditions before administration, and should seek immediate treatment if hypotensive symptoms occur after taking the medication. Patients at risk for hyperkalemia should undergo regular blood tests, as blood potassium levels may rise, and should be careful when taking potassium supplements or potassium-rich medications. Patients with impaired kidney function should frequently check their status through blood tests, as the risk of worsening kidney function exists. While taking this medication, caution is advised when driving or operating dangerous machinery, as dizziness or drowsiness may occur. Interactions may occur with other medications; therefore, consult a healthcare provider if taking other medications. In case of overdose, severe hypotension, dizziness, arrhythmia, etc., may occur, and immediate medical attention should be sought. This medication should be kept out of reach of children, and it is recommended to store the product sealed and to open it just before taking it.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 101 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory abnormalities
  • sensory loss
  • taste abnormalities
  • tremors
  • extrapyramidal disorders
  • muscle hypertonia
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • intragastric air retention
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver function abnormalities
  • liver dysfunction
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal function impairment
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased serum creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that blocks light. It is also recommended to store it at room temperature between 1 degree and 30 degrees Celsius to maintain its effectiveness and safety.

Appearance and packaging

Appearance

Biconvex, double-layered tablet, white and light blue in color

Package unit

30 tablets (10 tablets/PTP X 3), 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.